Nathaniel D. Kirkpatrick, Ph.D. - Publications

Affiliations: 
2006 University of Arizona, Tucson, AZ 
Area:
Biomedical Engineering

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Voutouri C, Kirkpatrick ND, Chung E, Mpekris F, Baish JW, Munn LL, Fukumura D, Stylianopoulos T, Jain RK. Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies. Proceedings of the National Academy of Sciences of the United States of America. PMID 30700544 DOI: 10.1073/Pnas.1818322116  0.343
2016 Kloepper J, Riedemann L, Amoozgar Z, Seano G, Susek K, Yu V, Dalvie N, Amelung RL, Datta M, Song JW, Askoxylakis V, Taylor JW, Lu-Emerson C, Batista A, Kirkpatrick ND, et al. Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival. Proceedings of the National Academy of Sciences of the United States of America. PMID 27044098 DOI: 10.1073/Pnas.1525360113  0.319
2016 Peterson TE, Kirkpatrick ND, Huang Y, Farrar CT, Marijt KA, Kloepper J, Datta M, Amoozgar Z, Seano G, Jung K, Kamoun WS, Vardam T, Snuderl M, Goveia J, Chatterjee S, et al. Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages. Proceedings of the National Academy of Sciences of the United States of America. PMID 27044097 DOI: 10.1073/Pnas.1525349113  0.323
2016 Kloepper J, Riedemann L, Amoozgar Z, Seano G, Susek KH, Yu V, Dalvie N, Amelung RL, Datta M, Song JW, Askoxylakis V, Taylor JW, Lu-Emerson C, Batista A, Kirkpatrick ND, et al. Abstract LB-347: Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-347  0.339
2016 Amoozgar Z, Peterson TE, Kirkpatrick ND, Huang Y, Farrar CT, Marijt KA, Kloepper J, Datta M, Seano G, Jung K, Kamoun WS, Vardam T, Snuderl M, Goveia J, Chatterjee S, et al. Abstract LB-346: Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-346  0.349
2016 Peterson T, Kirkpatrick N, Huang Y, Farrar C, Marjit K, Kloepper J, Datta M, Amoozgar Z, Seano G, Jung K, Kamoun W, Vardam T, Snuderl M, Goveia J, Chatterjee S, et al. Tmic-07. Dual Inhibition Of Ang-2 And Vegf Receptors Normalizes Tumor Vasculature And Prolongs Survival In Glioblastoma By Altering Macrophages Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.847  0.304
2014 Snurdel M, Batista A, Kirkpatrick N, Almodovar C, Riedemann L, Peterson T, Ferrara N, Klagsbrun M, Duda DG, Fukumura D, Xu L, Carmeliet P, Jain R. Abstract IA17: Targeting placental growth factor/ neuropilin-1 pathway inhibits growth and spread of medulloblastoma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-Ia17  0.367
2013 Goel S, Gupta N, Walcott BP, Snuderl M, Kesler CT, Kirkpatrick ND, Heishi T, Huang Y, Martin JD, Ager E, Samuel R, Wang S, Yazbek J, Vakoc BJ, Peterson RT, et al. Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression. Journal of the National Cancer Institute. 105: 1188-201. PMID 23899555 DOI: 10.1093/Jnci/Djt164  0.319
2013 Snuderl M, Batista A, Kirkpatrick ND, Ruiz de Almodovar C, Riedemann L, Walsh EC, Anolik R, Huang Y, Martin JD, Kamoun W, Knevels E, Schmidt T, Farrar CT, Vakoc BJ, Mohan N, et al. Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma. Cell. 152: 1065-76. PMID 23452854 DOI: 10.1016/J.Cell.2013.01.036  0.317
2013 Riedemann L, Snuderl M, Batista A, Kirkpatrick ND, Ruiz de Almodovar C, Hasselblatt M, Rossig C, Duda GD, Xu L, Fukumura D, Carmeliet P, Jain RK. Neuropilin-1 (Nrp-1) as a prognostic biomarker and potential drug target for pediatric medulloblastoma. Journal of Clinical Oncology. 31: 2056-2056. DOI: 10.1200/Jco.2013.31.15_Suppl.2056  0.308
2013 Lu-Emerson C, Snuderl M, Kirkpatrick ND, Goveia J, Taylor J, Davidson C, Huang Y, Riedemann L, Ivy SP, Duda GD, Ancukiewicz M, Plotkin SR, Chi A, Gerstner ER, Eichler AF, et al. Abstract LB-339: Increase in tumor-associated macrophages (TAMs) after antiangiogenic therapy is associated with poor survival in recurrent glioblastoma (GBM) patients. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-339  0.308
2012 Wong HK, Shimizu A, Kirkpatrick ND, Garkavtsev I, Chan AW, di Tomaso E, Klagsbrun M, Jain RK. Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism. Neoplasia (New York, N.Y.). 14: 84-94. PMID 22431917 DOI: 10.1593/Neo.111600  0.302
2011 Perentes JY, Kirkpatrick ND, Nagano S, Smith EY, Shaver CM, Sgroi D, Garkavtsev I, Munn LL, Jain RK, Boucher Y. Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors. Cancer Research. 71: 4527-38. PMID 21571860 DOI: 10.1158/0008-5472.Can-10-4376  0.335
2011 Duda DG, Kozin SV, Kirkpatrick ND, Xu L, Fukumura D, Jain RK. CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 2074-80. PMID 21349998 DOI: 10.1158/1078-0432.Ccr-10-2636  0.359
2010 Snuderl M, Kirkpatrick ND, Walsh EC, Chung E, Kamoun WS, Peterson TE, Munn LL, Duda DG, Fukumura D, Carmeliet P, Xu L, Jain RK. Abstract LB-363: Inhibition of placental growth factor (PlGF) leads to regression of medulloblastoma Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-363  0.363
2010 Kirkpatrick ND, Jain RK. Abstract 368: In vivo vessel co-option by glioma cells following chronic anti-angiogenic treatment Cancer Research. 70: 368-368. DOI: 10.1158/1538-7445.Am10-368  0.391
2009 Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Research. 69: 2260-8. PMID 19276390 DOI: 10.1158/0008-5472.Can-07-5575  0.342
2008 Udovich JA, Kirkpatrick ND, Kano A, Tanbakuchi A, Utzinger U, Gmitro AF. Spectral background and transmission characteristics of fiber optic imaging bundles. Applied Optics. 47: 4560-8. PMID 18758526 DOI: 10.1364/Ao.47.004560  0.596
2008 Black KC, Kirkpatrick ND, Troutman TS, Xu L, Vagner J, Gillies RJ, Barton JK, Utzinger U, Romanowski M. Gold nanorods targeted to delta opioid receptor: plasmon-resonant contrast and photothermal agents. Molecular Imaging. 7: 50-7. PMID 18384724 DOI: 10.2310/7290.2008.0007  0.591
2007 Kirkpatrick ND, Brewer MA, Utzinger U. Endogenous optical biomarkers of ovarian cancer evaluated with multiphoton microscopy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2048-57. PMID 17932352 DOI: 10.1158/1055-9965.Epi-07-0009  0.624
2007 Kirkpatrick ND, Andreou S, Hoying JB, Utzinger U. Live imaging of collagen remodeling during angiogenesis. American Journal of Physiology. Heart and Circulatory Physiology. 292: H3198-206. PMID 17307995 DOI: 10.1152/Ajpheart.01234.2006  0.631
2006 Kirkpatrick ND, Hoying JB, Botting SK, Weiss JA, Utzinger U. In vitro model for endogenous optical signatures of collagen. Journal of Biomedical Optics. 11: 054021. PMID 17092170 DOI: 10.1117/1.2360516  0.654
2006 McNally JB, Kirkpatrick ND, Hariri LP, Tumlinson AR, Besselsen DG, Gerner EW, Utzinger U, Barton JK. Task-based imaging of colon cancer in the Apc(Min/+) mouse model. Applied Optics. 45: 3049-62. PMID 16639453 DOI: 10.1364/Ao.45.003049  0.641
2006 Brewer M, Kirkpatrick ND, Wharton JT, Wang J, Hatch K, Auersperg N, Utzinger U, Gershenson D, Bast R, Zou C. 4-HPR modulates gene expression in ovarian cells. International Journal of Cancer. 119: 1005-13. PMID 16570282 DOI: 10.1002/Ijc.21797  0.618
2006 Kirkpatrick ND, Utzinger U. Fluorescence spectroscopy and SHG imaging of an in vitro collagen model Biosilico. DOI: 10.1364/Bio.2006.Me55  0.644
2005 Kirkpatrick ND, Zou C, Brewer MA, Brands WR, Drezek RA, Utzinger U. Endogenous fluorescence spectroscopy of cell suspensions for chemopreventive drug monitoring. Photochemistry and Photobiology. 81: 125-34. PMID 15535738 DOI: 10.1562/2004-08-09-Ra-267.1  0.649
2005 Kirkpatrick ND, Brewer MA, Utzinger U. Characterization of In Vitro Ovarian Tissue Fluorescence with Multiphoton Microscopy Frontiers in Optics. DOI: 10.1364/Fio.2005.Jmd4  0.635
2005 Udovich J, Kirkpatrick N, Tanbakuchi A, Gmitro AF. Fluorescence spectral characteristics of fiber optic imaging bundles Frontiers in Optics. DOI: 10.1364/Fio.2005.Ftug2  0.41
2005 Hariri LP, McNally JB, Kirkpatrick ND, Tumlinson AR, Besselsen DG, Gerner EW, Utzinger U, Barton JK. Imaging of Colon Cancer in a Mouse Model (ApcMin) Frontiers in Optics. DOI: 10.1364/Fio.2005.Fmc3  0.652
2005 Utzinger U, Kirkpatrick ND, Drezek RA, Brewer MA. Endogenous fluorescence emission of the ovary Progress in Biomedical Optics and Imaging - Proceedings of Spie. 5702: 92-96. DOI: 10.1117/12.591378  0.645
2005 Kirkpatrick ND, Brands WR, Zou C, Brewer MA, Utzinger U. Intrinsic fluorescence biomarkers in cells treated with chemopreventive drugs Progress in Biomedical Optics and Imaging - Proceedings of Spie. 5699: 255-262. DOI: 10.1117/12.591363  0.65
2005 Hariri LP, McNally JB, Kirkpatrick ND, Tumlinson AR, Besselsen DG, Gerner EW, Utzinger U, Barton JK. Imaging of colon cancer in a mouse model (ApcMin) Optics Infobase Conference Papers 0.623
2004 Brewer MA, Utzinger U, Barton JK, Hoying JB, Kirkpatrick ND, Brands WR, Davis JR, Hunt K, Stevens SJ, Gmitro AF. Imaging of the ovary. Technology in Cancer Research & Treatment. 3: 617-27. PMID 15560720 DOI: 10.1177/153303460400300612  0.675
Show low-probability matches.